|
Showing the most relevant articles for your search:AMEX:ANX Date | Time | Source | Headline | Symbol | Company | 12/09/2011 | 4:22PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
12/09/2011 | 3:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
12/09/2011 | 3:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
12/09/2011 | 3:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
12/09/2011 | 3:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
12/02/2011 | 12:05PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
12/02/2011 | 3:14AM | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | AMEX:ANX | Mast Therapeutics, Inc. |
12/01/2011 | 8:30AM | PR Newswire (US) | ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
11/21/2011 | 5:09PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | AMEX:ANX | Mast Therapeutics, Inc. |
11/21/2011 | 4:51PM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | AMEX:ANX | Mast Therapeutics, Inc. |
11/16/2011 | 3:41PM | PR Newswire (US) | ADVENTRX Announces Closing of Public Offering | AMEX:ANX | Mast Therapeutics, Inc. |
11/15/2011 | 8:16AM | Marketwired | Speculative Healthcare Companies IntelGenx and Adventrx Begin to Gain Ground | AMEX:ANX | Mast Therapeutics, Inc. |
11/14/2011 | 4:57PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | AMEX:ANX | Mast Therapeutics, Inc. |
11/14/2011 | 4:51PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
11/11/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Prices Public Offering of Stock | AMEX:ANX | Mast Therapeutics, Inc. |
11/10/2011 | 5:24PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | AMEX:ANX | Mast Therapeutics, Inc. |
11/10/2011 | 4:28PM | PR Newswire (US) | ADVENTRX Announces Public Offering of Stock | AMEX:ANX | Mast Therapeutics, Inc. |
11/09/2011 | 4:16PM | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | AMEX:ANX | Mast Therapeutics, Inc. |
11/08/2011 | 6:08AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ANX | Mast Therapeutics, Inc. |
11/07/2011 | 11:47AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
11/07/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Reports Third Quarter 2011 Financial Results | AMEX:ANX | Mast Therapeutics, Inc. |
10/26/2011 | 9:05AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
10/26/2011 | 8:16AM | Marketwired | Drug Approval Rate Stagnant -- Nektar and ADVENTRX Look to Defy Odds | AMEX:ANX | Mast Therapeutics, Inc. |
10/26/2011 | 8:00AM | PR Newswire (US) | ADVENTRX and FDA Reach Agreement on Pivotal Study for ANX-514 | AMEX:ANX | Mast Therapeutics, Inc. |
10/19/2011 | 8:00AM | PR Newswire (US) | ADVENTRX Pharmaceuticals to Present at the 10th Annual BIOInvestor Forum Conference on October 26 | AMEX:ANX | Mast Therapeutics, Inc. |
10/14/2011 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | AMEX:ANX | Mast Therapeutics, Inc. |
10/06/2011 | 4:32PM | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | AMEX:ANX | Mast Therapeutics, Inc. |
10/04/2011 | 8:16AM | Marketwired | ADVENTRX Pharmaceuticals and Cell Therapeutics Look Promising as Fourth Quarter Kicks Off | AMEX:ANX | Mast Therapeutics, Inc. |
09/30/2011 | 5:06PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
09/30/2011 | 4:30PM | PR Newswire (US) | ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|